National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification and strratification. Am J Kidney Dis 2002 ; 39 : S1-266.
Chitalia VC, Kothari J, Wells EJ, Livesey JH, Robson RA, Searle M, et al. Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio. Clin Nephrol 2001 ; 55 : 436-47.
Mitchell SCM, Sheldon TA, Shaw AB. Quantification of proteinuria : A re-evaluation of the protein/creatinine ratio for elderly subjects. Age Ageing 1993 ; 22 : 443-9.
Price CP, Newall RG, Boyd JC, Young DS. Use of protein : creatinine ratio measurements on random urine samples for prediction of significant proteinuria : A systematic review. Clin Chem 2005 ; 51 : 1577-86.
Hohan MC, Reich HN, Nelson PJ, Adler SG, Cattran DC, Appel GB, et al. The relatively poor correlation between random and 24-hour urine protein excretion in patients with biopsy-proven glomerular diseases. Kidney Int 2016 ; 90 : 1080-9.
Medina-Rosas J, Yaps KS, Anderson M, Su J, Touma Z. Utility of urinary protein-creatinine ratio and protein content in a 24-hour urine collection in systemic lupus erythematosus : A systematic reviewand metaanalysis. Arthritis Care Res 2016 ; 68 : 1310-9.
Ying T, Clayton P, Naresh C, Chadban S. Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression. BMC Nephrology 2018 ; 19 : 55-63.
Talreja H, Akbari A, White CA, Ramsay TO, Hiremath S, Knoll G. Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections. Am J Kidney Dis 2014 ; 64 : 962-8.
Ruggenenti P, Gaspari F, Perna A, Remuzzi G. Cross sectional longitudinal study of spot morningurine proteine/creatinine ratio, 24 hour urines protein excretion rate, glomerular filtration rate, and end-stage renal failure in chronic renal disease in patients without diabetes. BMJ 1998 ; 316 : 504-9.
Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H. Measures of urinary protein and albumin in the prediction of progression of IgA nephropathy. Clin J Am Soc Nephrol 2016 ; 11 : 947-55.
Methven S, MacGregor MS, Traynor JP, Hair M, O'Reilly DSJ, Deighan CJ. Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD. YAJKD 2011 ; 57 : 21-8.
Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH, Shahinfar S, et al. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010 ; 21 : 1355-60.
Vathsala A, Verani R, Schoenberg L, Lewis RM, Van Buren CT, Kerman RH, et al. Proteinuria in cyclosporine-treated renal transplant recipients. Transplantation 1990 ; 49 : 35-41.
Fernández-Fresnedo G, Escallada R, Rodrigo E, De Francisco AL, Cotorruelo JG, Sanz De Castro S, et al. The risk of cardiovascular disease associated with proteinuria in renal transplant patients. Transplantation 2002 ; 73 : 1345-8.
Fernandez-Fresnedo G, Escallada R, Rodrigo E, Pinera C, de Francisco AL, Cotorruelo JG, et al. Proteinuria is an independant risk factor of cardiovascular disease in renal transplant patient. Transplant Proc 2002 ; 34 : 367.
KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 2009 ; 9 (Suppl. 3) : S1-S157.
Akbari A, White CA, Shahbazi N, Booth RA, Hiremath S, Knoll GA. Spot urine measurements : are these accurate in kidney transplant recipients ? Tansplantation 2012 ; 94 : 389-95.
Koopman MG, Krediet RT, Koomen GC. Circadian rythm of proteinuria : consequences of the use urinary protein/creatinine ratios. Nephrol Dial Transplant 1989 ; 4 : 9-14.
Ke Wang M, White C, Akbari A, Brown P, Hussain N, Hiremath S, et al. Utilizing estimated creatinine excretion to improve the performance of spot urine samples for the determination of proteinuria in kidney transplant recipients. Plos One 2016 ; 11 : e0166547.
Lentine K, Kasiske BL, Levey AS, Adams PL, Alberu J, Bakr MA, et al. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation 2017 ; 101 : S7-105.
Abalos E, Cuestas C, Grosso AL, Chou D, Say L. Global and regional estimates of preeclampsia and eclampsia/a systematic review. Eur J Obstet Gynecol Reprod Biol 2013 ; 170 : 1-7.
Society for obstetric medicine in Australia and New Zealand. Guidelines for the management of hypertensive disorders of pregnancy 2014, http://www.somanz.org.
Cade TJ, Gilbert SA, Polyakov A, Hotchin A. The accuracy of spot urinary protein-to-creatinine ratio in confirming proteinuria in pre-eclampsia. Aust N Z J Obstet Gynaecol 2012 ; 52 : 179-82.
Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia : systematic review and meta-analysis. BMJ 2012 ; 345 : e4342.
Cade TJ, Champion de Crespigny P, Nguyen T, Cade JR, Umstad MP. Should the spot albumin-to-creatinine ratio replace the spot protein-tocreatinine ratio as the primary screening tool for proteinuria in pregnancy ? Pregnancy Hypertens 2015 ; 5 : 298-302.
Yang EM, Yoon BA, Kim SW, Kim CJ. Clinical utility of spot urine protein-to-creatinine ratio modified by estimated daily creatinine excretion in children. Pediatr Nephrol 2017 ; 32 : 1045-51.
Filler G, Huang SH. Spot urine protein to creatinine ratio. Pediatr Nephrol 2017 ; 32 : 917-9.
American diabetes association position statement. Standards of medical care in diabetes. Diabetes Care 2007 ; 30 : S19-21.
International diabetes federation clinical guidelines task force. Global guidelines for type 2 diabetes ; Chapter 14 : kidney damage. http://www.idf.org.
Actualisation du référentiel de pratiques de l'examen périodique de santé. Prévention et dépistage du diabète de type 2 et des maladies liées au diabète, 2014, accessible sur le site www.has.fr.
Fiche mémo Prise en charge de l'hypertension artérielle de l'adulte, 2016, accessible sur le site www.has-sante.fr.
KDIGO Clinical practice guidelines for the evaluation and management of chronic kidney disease. Volume 3, 2013, http ://www.kidneyinternational. org.
De Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria : public health perspectives. J Am Soc Nephrol 2006 ; 17 : 2120-6.
Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, et al. Microalbuminurie et excrétion urinaire d'albumine : recommandations pour la pratique clinique. Ann Biol Clin 2008 ; 66 : 277-84.
Guide du parcours de soins-Maladie rénale chronique de l'adulte de la HAS, Annexe 2 : Dosages urinaires des protéines et de l'albumine : tests et expressions équivalentes, 2012, p 32, accessible sur le site www.has.fr.
Recommandations formalisées d'experts. Agence de la biomédecine, Association française d'étude du foie-AFEF, Association de chirurgie hépato-biliaire et de transplantation hépatique-ACHBT, Association française d'urologie-AFU, Association française d'anesthésieréanimation-SFAR, Société francophone de transplantation-SFT, Société de néphrologie-SN, 2009, accessible sur le site www.agencebiomedecine. fr.
Actualisation du référentiel de pratiques de l'examen périodique de santé-Prévention et dépistage du diabète de type 2 et des maladies liées au diabète, 2014, p 43, accessible sur le site www.has.fr.
Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. Synthèse des recommandations professionnelles, 2016, accessible sur le site www.has.fr.
Prise en charge multidisciplinaire des formes graves de pré éclampsie. Recommandations formalisées d'experts communes à la Société française d'anesthésie et de réanimation (SFAR), au collège national des gynécologues et obstétriciens français (CNGOF), à la Société française de néonatologie (SFNN) et à la Société française de médecine périnatale (SFMP), 2009, accessible sur le site www.sfar.org.
Recommandations pour la pratique clinique/HTA et grossesse, 2015, accessible sur le site http://www.cngof.fr.
Naresh CN, Hayen A, Weening A, Craig JC, Chadban SJ. Day-today variability in spot urine albumin-creatinine ratio. Am J Kidney Dis 2013 ; 62 : 1095-101.
Viswanathan G, Upadhyay A. Assessment of proteinuria. Adv Chronic Kidney Dis 2011 ; 18 : 243-8.
Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, McGilveray IJ, et al. Bioanalytical method validation-A revisit with a decade of progress. Pharm Res 2000 ; 17 : 1551-7.
Xin G,Wang M, Jiao L, Xu G,Wang H. Protein-to-creatinine ratio in spot urine samples as a predictor of quantitation of proteinuria. Clin Chim Acta 2004 ; 350 : 35-9.
Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, et al. KHA-CARI guideline : early chronic kidney disease : detection, prevention and management. Nephrology 2013 ; 18 : 340-50.
Johnson DW. Global proteinuria guidelines : are we nearly there yet ? Clin Biochem Rev 2011 ; 32 : 89-95.
Fotheringham J, Weatherley N, Kawar B, Fogarty D, Ellam T. The body composition and excretory burden of lean, obese, and severely obese individuals has implications for the assessment of chronic kidney disease. Kidney Int 2014 ; 86 : 1221-8.
Evaluation du rapport albuminurie/créatininurie dans le diagnostic de la maladie rénale chronique chez l'adulte, 2011, accessible sur le site www.has.fr.
Inker LA. Albuminuria : time to focus on accuracy. Am J Kidney Dis 2014 ; 63 : 378-81.
Nice clinical guideline 73, accessible sur le site https://www.nice.org. uk/guidance/cg73.
